A Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valganciclovir (Valcyte®) Versus Untreated Matched Controls
Public ClinicalTrials.gov record NCT01663740. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Prospective Cohort Study to Investigate if Ganciclovir Significantly Affects Spermatogenesis in Adult Male Renal Transplant Recipients Receiving up to 200 Days Valganciclovir Vs. Concurrent Untreated Matched Controls
Study identification
- NCT ID
- NCT01663740
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 59 participants
Conditions and interventions
Conditions
Interventions
- Valganciclovir Drug
Drug
Eligibility (public fields only)
- Age range
- 20 Years to 50 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 29, 2012
- Primary completion
- Sep 28, 2015
- Completion
- Dec 29, 2016
- Last update posted
- Aug 30, 2018
2012 – 2016
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Institute of Transplantation | Los Angeles | California | 90057 | — |
| University of California Los Angeles (UCLA) | Los Angeles | California | 90095 | — |
| University of California at San Francisco | San Francisco | California | 94115 | — |
| Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Medical College of Georgia | Augusta | Georgia | 30912 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Western New England Renal & Transplant Associates, P.C. | Springfield | Massachusetts | 01107 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Mayo Clinic Rochester | Rochester | Minnesota | 55902 | — |
| Albany Medical Cancer Center | Albany | New York | 12208 | — |
| University at Buffalo | Buffalo | New York | 14203 | — |
| Stony Brook University Hospital | Stony Brook | New York | 11794 | — |
| Oregan Health & Science Univ | Portland | Oregon | 97237 | — |
| Drexel University Department of Nephrology | Philadelphia | Pennsylvania | 19102 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| Methodist Healthcare System of San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01663740, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 30, 2018 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01663740 live on ClinicalTrials.gov.